论文部分内容阅读
目前,临床上对于慢性乙型病毒性肝炎抗病毒治疗的目的是抑制乙肝病毒(HBV)复制、减轻肝组织病变、改善肝功能、降低传染性、减轻或阻止肝硬化的发生、提高患者的生活质量[1]。2009年4月至2011年11月我院对收治的慢性乙肝轻中型患者分别单独应用α-2b干扰素和α-2b干扰素与苦参素联合应用抗病毒治疗,并对比观察两种疗法的临床效果,结果显示α-2b干扰素与苦参素联合应用可明显
At present, the clinical treatment of chronic hepatitis B virus antiviral therapy aims to inhibit the replication of hepatitis B virus (HBV), reduce liver disease, improve liver function, reduce infectious, reduce or prevent the occurrence of cirrhosis, improve patient’s life Quality [1]. April 2009 to November 2011 in our hospital on the treatment of chronic hepatitis B in patients with mild to moderate treatment of alpha 2b and alpha 2b interferon and oxymatrine combined antiviral therapy, and compared the two treatments Clinical results, the results show that α-2b interferon and oxymatrine combination can be obvious